Actuate Therapeutics Inc

NASDAQ: ACTU · Real-Time Price · USD
8.00
-0.22 (-2.68%)
At close: Aug 15, 2025, 3:59 PM
8.12
1.56%
After-hours: Aug 15, 2025, 04:10 PM EDT

Actuate Therapeutics Inc Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Net Income
-25.31M -27.29M -28.45M -28.82M -27.77M -24.74M -17.13M -10.79M -5.27M
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
2.97M 2M 926.26K 515.5K 498.61K 423.54K 301.49K 146.26K 73.13K
Other Working Capital
721.75K 2.6M 2.88M 4.01M 3.81M 1.28M 224.54K -112.22K -653.75K
Other Non-Cash Items
1.81M 2.35M 2.4M 1.73M 375.85K 330.29K 273.63K 285.43K 492.03K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-1.26M 1.1M 2.54M 7.5M 5.38M 2.37M 444.03K -112.22K -653.75K
Operating Cash Flow
-21.21M -21.84M -22.58M -19.07M -21.51M -21.63M -16.11M -10.48M -5.36M
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
-4.5M n/a 5.5M 5.5M 4.5M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
27.05M 27.04M 22.14M -185.73K 1.53M 4.13M 4.13M 4.13M 2.46M
Financial Cash Flow
23.03M 27.53M 27.64M 5.31M 6.03M 4.13M 4.13M 4.13M 2.46M
Net Cash Flow
1.82M 5.68M 5.05M -13.76M -15.49M 2.96M 8.47M 14.11M 17.55M
Free Cash Flow
-21.21M -21.84M -22.58M -19.07M -21.51M -21.63M -16.11M -10.48M -5.36M